검색어: pharmaceutical dosage forms (영어 - 몰타어)

equivalence with oral dosage forms
ekwivalenza ma’ forom ta’ dożaġġ orali

oral dosage forms of voriconazole are available from other manufacturers
forom ta’ dożaġġ orali ta’ voriconazole huma disponibbli minn manifatturi oħra

not all dosage forms and strengths are appropriate for some indications.
mhux il-forom tad-dożaġġi u qawwiet kollha jkunu xierqa għal xi indikazzjonijiet.

uth not all dosage forms and strengths are appropriate for some indications.
mhux il- forom kollha tad- dożaġġi u qawwiet ikunu xierqa għal xi indikazzjonijiet.

oral solid dosage form
forma ta’ dożaġġ orali solida

other etanercept products with appropriate dosage forms for children are available.
prodotti oħrajn ta’ etanercept bil-forom ta’ dożaġġ adattati għat-tfal huma disponibbli.

solid dosage forms of the tetracyclines may cause oesophageal irritation and ulceration.
forom ta ’ dożaġġ solidi ta ’ tetracyclines jistgħu jikkawżaw irritazzjoni u ulċerazzjoni ta ’ l- esofagu.

same functional characteristics, no change in dissolution profile for solid dosage forms.
l-istess karatteristiċi funzjonali, l-ebda bidla fil-profil tad-dissoluzzjoni għall-għamliet solidi tad-dożaġġ.

ge appropriate dosage form and strength.
jekk jogħġbok kun żgur li tgħażel il- forma tad- dożaġġ u qawwa xierqa.

in semi-solid dosage forms: amount equivalent to 2-10 % herbal substance.
f’forom ta’ dożaġġ semisolidu: ammont ekwivalenti għal sustanza veġetali ta’ 2-10 %.

the following data were generated using the viramune immediate-release tablets but are expected to apply to all dosage forms.
id-dejta li ġejja ġiet iġġenerata billi ntużaw viramune pilloli li jerħu l-mediċina fil-pront, iżda hu mistenni li d-dejta tapplika għall-forom kollha ta’ dożaġġ.

the rate and extent of absorption of amlodipine, valsartan and hydrochlorothiazide from copalia hct are the same as when administered as individual dosage forms.
ir-rata li biha jiġu assorbiti amlodipine, valsartan u hydrochlorthiazide minn copalia hct u sa liema punt huma l-istess bħal meta jingħataw bħala forom ta’ doża individwali.

please make sure to select an appropriate dosage form and strength.
jekk jogħġbok kun żgur li tagħżel il-forma tad-dożaġġ u qawwa li tkun xierqa.

please make sure to select an appropriate dosage form and strength. na
jekk jogħġbok kun żgur li tgħażel il- forma tad- dożaġġ u qawwa xierqa. me

the rate and extent of absorption of aliskiren, amlodipine and hydrochlorothiazide following administration of a fixed combination tablet are similar to when administered as individual dosage forms.
ir-rata u l-estensjoni tal-assorbiment ta’ aliskiren, amlodipine u hydrochlorothiazide wara l-għoti ta’ pillola b’kombinazzjoni fissa jixbhu lil dawk ta’ meta jingħataw forom ta' dożi individwali.

4.2.3 the various species of animals and various diseases require different forms of administration and this requires different pharmaceutical dosage forms (for example, liquids, solids, gels, injectables, etc.).
4.2.3 l-ispeċijiet differenti tal-annimali u l-mard differenti jeħtieġu forom differenti ta' amministrazzjoni, u dan jeħtieġ għamliet farmaċewtiċi differenti (pereżempju likwidi, solidi, ġell, injezzjonijiet, eċċ.).

after therapy has been initiated, the dose or dosage form must not be changed or therapy must not be stopped without instruction of the doctor.
wara li tinbeda l-kura, id-doża jew il-forma tad-dożaġġ m’għandiex tinbidel u l-kura m’għandiex titwaqqaf mingħajr ma jordna dan it-tabib.

due to the controlled-release design of the dosage form, invega should only be used in patients who are able to swallow the tablet whole.
minħabba d- disinn tal- forma tad- dożaġġ li jerħi l - mediċina bil- mod, invega għandu jintuża biss f’ pazjenti li jistgħu jibilgħu il- pillola sħiħa.

strength of the medicinal product: the content of the active substances expressed quantitatively per dosage unit, per unit of volume or weight according to the dosage form.
il-qawwa tal-prodott mediċinali: il-kontenut ta' sustanzi attivi espress kwantitattivament għal kull unità ta' dożaġġ, kull unità ta' volum jew piż skond il-forma tad-dożaġġ.

food, however, had no apparent effect on the post absorption phase concentration-time profile 24 hours post-dose of either dosage form.
l-ikel, madankollu, deher li ma kellux effett fuq il-profil ta’ konċentrazzjoni u ħin fil-fażi ta’ wara l- assorbiment 24 siegħa wara d-doża ta’ kwalunkwe forma ta’ dożaġġ.